Both Celastrol and compound 19-048 showed decreased IC50 values in gPRDX1 SW620 cells, suggesting that knockdown of PRDX1 could enhance the sensitivity of colorectal cancer cells to Celastrol and compound 19-048 (Fig. 5b). The gene discussed is PRDX1; the disease is colorectal cancer.